The sensitivity of this blood-based test for colorectal cancer was 83.1%, whereas reported sensitivity of other noninvasive screening tests ranges from 67.3% (95% CI, 57.1 to 76.5) with FIT 15 and ...

More information: Mohamed Adil et al, Preeclampsia risk prediction from prenatal cell-free DNA screening, Nature Medicine (2025). DOI: 10.1038/s41591-025-03509-w ...

More information: Hua Bao et al, Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics, Nature Medicine (2025). DOI: 10.1038/s41591-025-03735-2 ...

For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in most people confirmed to have the ...

Reference Chung DC, Gray II DM, Singh H, et al. A cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med. 2024;390 (11):973-983. doi:10.1056/NEJMoa2304714 ...

Secondary Source New England Journal of Medicine Source Reference: Vora NL "Cell-free DNA screening and maternal cancer" N Engl J Med 2024; DOI: 10.1056/NEJMe2412259.

More information: Mohamed Adil et al, Preeclampsia risk prediction from prenatal cell-free DNA screening, Nature Medicine (2025). DOI: 10.1038/s41591-025-03509-w ...

PURPOSEUsing the prostate, lung, colorectal, and ovarian (PLCO) Cancer Screening Trial samples, we identified cell-free DNA (cfDNA) candidate biomarkers bearing the epigenetic mark ...

The usefulness of the cell-free DNA blood test (cf-bDNA) can vary based on the reasons for using the method of screening for colorectal cancer (CRC). According to a new study published in Annals ...